1型糖尿病、2型糖尿病和妊娠糖尿病患者孕期血糖正常范围内时间、血糖变异性及其它葡萄糖管理指标的差异

This is a highlights summary of an oral session given at the ADA 2020 - 80^th Scientific Sessions and presented by:

Sarit Polsky, MD
University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Denver, CO, USA

The content is produced by Infomedica, the official reporting partner of ADA 2020 Virtual Meeting. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Dana M. Dabelea, MD, PhD, the scientific editor of the program.

The presenting authors of the original session had no part in the creation of this conference highlights summary.

Denice Feig, MD, MSc, FRCPC
Professor of Medicine, Obstetrics & Gynecology, and Health Policy, Management & Evaluation, University of Toronto
Clinician Scientist, Lunenfeld-Tanenbaum Research Institute,
Head, Diabetes & Endocrinology in Pregnancy Program

Dr. Feig is head of the Diabetes in Pregnancy Program at Mount Sinai Hospital and University Health Network. She is professor at University of Toronto in the Department of Medicine, and has a Master's degree in clinical epidemiology. She is cross-appointed to both the Department of Obstetrics and Gynaecology and the Institute of Health Policy, Management and Evaluation. She is currently the chair of the American Diabetes Association Pregnancy Planning Committee, the past chair of the Canadian Diabetes in Pregnancy Study Group, the current chair of the University of Toronto/BBDC Diabetes in Pregnancy Study Group, and sits on the International Diabetes in Pregnancy Study Group. She participated in the recent CDA Clinical Practice Guidelines in the area of pregnancy. She has numerous grants and publications in the area of diabetes and pregnancy.